发明名称 ACTIVATORS FOR OLIGONUCLEOTIDE SYNTHESIS
摘要 A process for the synthesis of oligonucleotides using phosphoramidite chemistry is provided. The process employs as activator a 1,1-dioxo-1,2- dihydro-1.lambda.6-benzo[d]isothiazol-3-one, preferably in the presence of a n organic base. The 1,1-dioxo-1,2-dihydro-1.lambda.6-benzo[d]isothiazol-3-one is represented by the following structural formula: (I); wherein p is 0 or an integer from 1 to 4; X7 is O or S; R for each occurence is a substituent, preferably each independently, a halo, a substituted or unsubstituted aliphatic group, -NR11R12, -OR13, -OC(O)R13, -C(O)OR13, or cyano; or two adjacent R groups taken together with the carbon atoms to which they are attached form a six membered saturated or unsaturated ring; R11 and R12 are each, independently, -H, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted aralkyl group; and R13 is a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted aralkyl group. Preferred organic bases are pyridine, 3-methylpyridine, or N- methylimidazole.
申请公布号 CA2452205(A1) 申请公布日期 2003.01.16
申请号 CA20022452205 申请日期 2002.07.01
申请人 AVECIA BIOTECHNOLOGY INC. 发明人 SINHA, NANDA;ZEDALIS, WILLIAM EDWARD;MIRANDA, GREGORY KEITH
分类号 C07D213/18;C07D233/58;C07D275/06;C07D521/00;C07F9/6558;C07F9/6561;C07H21/00;C07H21/04;(IPC1-7):C07H21/00 主分类号 C07D213/18
代理机构 代理人
主权项
地址